Premium
A New Dual‐Chamber Pacing Mode to Minimize Ventricular Pacing
Author(s) -
SAVOURÉ ARNAUD,
FRÖHLIG GERD,
GALLEY DANIEL,
DEFAYE PASCAL,
REUTER SYLVAIN,
MABO PHILIPPE,
SADOUL NICOLAS,
AMBLARD AMEL,
LIMOUSIN MARCEL,
ANSELME FREDERIC
Publication year - 2005
Publication title -
pacing and clinical electrophysiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.686
H-Index - 101
eISSN - 1540-8159
pISSN - 0147-8389
DOI - 10.1111/j.1540-8159.2005.00095.x
Subject(s) - medicine , ventricular pacing , cardiac pacing , single chamber , cardiology , dual (grammatical number) , heart failure , art , literature
Despite the low long‐term incidence of high‐degree atrioventricular (AV) block and the known negative effects of ventricular pacing, programming of the AAI mode in patients with sinus node dysfunction (SND) remains exceptional. A new pacing mode was, therefore, designed to combine the advantages of AAI with the safety of DDD pacing. AAIsafeR behaves like the AAI mode in absence of AV block. First‐ and second‐degree AV blocks are tolerated up to a predetermined, programmable limit, and conversion to DDD takes place in case of high‐degree AV block. From DDD, the device may switch back to AAI, provided AV conduction has returned. The safety of AAIsafeR was examined in 43 recipients (70 ± 12‐year old, 24 men) of dual chamber pacemakers implanted for SND or paroxysmal AV block. All patients underwent 24‐hour ambulatory electrocardiographic recordings before hospital discharge and at 1 month of follow‐up with the AAIsafeR mode activated. No AAIsafeR‐related adverse event was observed. At 1 month, the device was functioning in AAIsafeR in 28 patients (65%), and the mean rate of ventricular pacing was 0.2%± 0.4%. Appropriate switches to DDD occurred in 15 patients (35%) for frequent, unexpected AV block. AAIsafeR mode was safe and preserved ventricular function during paroxysmal AV block, while maintaining a very low rate of ventricular pacing. The performance of this new pacing mode in the prevention of atrial fibrillation will be examined in a large, controlled study.